These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8314977)

  • 21. Trial of routine gonadotropin releasing hormone agonist treatment before abdominal hysterectomy for leiomyoma.
    Balasch J; Manau D; Mimó J; Duran M; Puerto B; Vanrell JA
    Acta Obstet Gynecol Scand; 1995 Aug; 74(7):562-5. PubMed ID: 7618457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
    Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Macro-microscopic changes in the uterine tube in uterine myoma].
    Brodskiĭ GV
    Morfologiia; 1999; 116(5):65-8. PubMed ID: 10581578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy.
    Khan KN; Kitajima M; Hiraki K; Fujishita A; Sekine I; Ishimaru T; Masuzaki H
    Hum Reprod; 2010 Mar; 25(3):642-53. PubMed ID: 20008888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.
    Schneider D; Golan A; Bukovsky I; Pansky M; Caspi E
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):540-1. PubMed ID: 1831252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
    Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone (GnRH) action on uterine leiomyomata is not mediated by uterine GnRH receptors.
    Neuman M; Langer R; Golan A; Bukovsky I; Caspi E; Koch Y
    Fertil Steril; 1991 Aug; 56(2):364-6. PubMed ID: 1649060
    [No Abstract]   [Full Text] [Related]  

  • 28. Uterine myoma after cessation of gonadotropin-releasing hormone agonist: ultrasound and histopathologic findings.
    Wang PH; Yang AH; Yuan CC; Lee WL; Chao HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Nov; 61(11):625-9. PubMed ID: 9872018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine adenocarcinoma after GnRH agonist treatment.
    Dessole S; Ruiu GA; Cherchi PL; Ambrosini G
    Arch Gynecol Obstet; 2000 Feb; 263(3):148-9. PubMed ID: 10763848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical application of GnRHa before uterine myomectomy: report of 20 cases].
    Yu YH; Gong SP; Wan SM
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):317-9. PubMed ID: 15041550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triptorelin to prevent hysterectomy in patients with leiomyomas.
    van Leusden HA
    Lancet; 1988 Aug; 2(8609):508. PubMed ID: 2900426
    [No Abstract]   [Full Text] [Related]  

  • 32. Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles.
    Golan A; Herman A; Soffer Y; Bukovsky I; Caspi E; Ron-El R
    Hum Reprod; 1993 Sep; 8(9):1372-5. PubMed ID: 8253920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptom-free interval after triptorelin treatment of uterine fibroids: long-term results.
    van Leusden HA
    Gynecol Endocrinol; 1992 Sep; 6(3):189-98. PubMed ID: 1442164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of GnRH analog premedication in hysteroscopic myoma resection].
    Todorow S; Siebzehnrübl E; Tulusan A; Lang N
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():25-7. PubMed ID: 8118296
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fetal outcome following "accidental" administration of a long-acting DTRP6 GnRh depot preparation during the first trimester of pregnancy].
    Rocco V
    Minerva Ginecol; 1992 Nov; 44(11):585-6. PubMed ID: 1480307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Triptorelin therapy in uterine leiomyomatosis. Study of 18 cases].
    Zarcone R; Monarca M; Vullo G; Bellini P; Carfora E; Tartaglia E
    Minerva Ginecol; 1998; 50(1-2):39-42. PubMed ID: 9577154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of add-back therapy with tibolone on myoma uteri.
    Göçmen A; Kara IH; Karaca M
    Clin Exp Obstet Gynecol; 2002; 29(3):222-4. PubMed ID: 12519049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of ectopic pregnancy following GnRH agonist triggering compared with hCG triggering in GnRH antagonist IVF cycles.
    Sahin S; Ozay A; Ergin E; Turkgeldi L; Kürüm E; Ozornek H
    Arch Gynecol Obstet; 2015 Jan; 291(1):185-91. PubMed ID: 25078054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of pre-ovulatory gonadotrophin surge with gonadotrophin-releasing hormone agonist compared to pre-ovulatory injection of human chorionic gonadotrophins for ovulation induction in intrauterine insemination treatment cycles.
    Shalev E; Geslevich Y; Matilsky M; Ben-Ami M
    Hum Reprod; 1995 Sep; 10(9):2244-7. PubMed ID: 8530644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complication of triptorelin treatment for uterine myomas.
    Ellenbogen A; Shulman A; Libal Y; Jaschevatzky O; Anderman S; Grunstein S
    Lancet; 1989 Jul; 2(8655):167-8. PubMed ID: 2567943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.